Company Profile

Year Established : 1958
Total Assets(USD) : 500,000 to 99,999,999
Total Number of Staff : 500-1000
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Led by technology innovation, based on biological fermentation, in the direction of semi-synthetic API research and development, Fujian Fukang Pharmaceutical Co., Ltd. aims to develop integral business of APIs and dosage form.The company focuses on four business sectors, biological fermentation products, chemically synthesized Cephalosporin APIs and dosage forms, chemically synthesized antiviral APIs and dosage forms, and animal health products.The company carries out consistency evaluation of dosage forms,gives full play of its advantages of international registration,expands regulated markets,reinforces cooperation with transnational corporations,to promote the rapid development.

In 1958, Fuzhou First Antibiotic Factory was established. In 2002, the plant was restructured into a private company, Fujian Fukang Pharmaceutical Co., Ltd..In 2003, the Jiangyin plant was established, covering an area of 300,000 square meters, and 23 buildings. The building area is 220,000 square meters.The company owns a complete industry chain and production lines. The production capacity per year is up to thousand tons.

The company is located in the provincial chemical and pharmaceutical industry zone and has a unique geographical advantage.The waste water treatment facility covers an area of 23, 333 square meters. The volume of waste water tanks reaches 65,000 cubic meters. There is a surplus of the capacity of the waste water facility.

Technology development and R&D innovation, and international technical cooperation are the long-term goals of the company.With ever-improving quality of products, international marketing expands.The production lines of antibiotic APIs and Cephalosporin dosage forms passed Chinese GMP certification.The production lines of main products are with CEP certificates from EDQM,and successfully passed US FDA inspections,EU GMP certification by German Health authorities,and GMP inspection by Japan PMDA.The quality of the products is at the leading place of international market.

Since our own export business was operated in1988, the company has established partnerships with about 150 companies over 35 nations and regions, including some of top 50 pharmaceutical companies in the world.The company established sales network over international regulated markets with excellent quality of products and services. The annual export revenue reaches $30 million.

Fujian Fukang always serves the health of the public with the best products, and contributes to the health of human beings. Thank you for constant care and support. Let’s create the future together.

PharmaSources Customer Service